← Latest Filings
P
Perceptive Advisors LLC
Also a 13F filer: see its fund portfolio and quarterly moves →
Open-market buys
1
$7.5M total
Open-market sells
5
$3.8M total
Tracking since
Apr 2025
Activity timeline
Open-market buy — $7.5M
Immatics N.V. · Aug 26, 2026
Open-market sale — $401K
Acrivon Therapeutics, Inc. · May 1, 2025
Open-market trades from the last two years.
Holdings as last reported
11,246,516 Ordinary Shares in IMTX
Held indirectly (See Footnote) · as of 2026-08-26
10,871,847 Common Stock in PCSC
Held indirectly (See Footnote) · as of 2026-07-20
Companies touched
Immatics N.V.
CIK 0001809196
Yarrow Bioscience, Inc.
CIK 0001566044
